Column company_description

Dataset List of investment funds, private equity and VC firms investing in Western Europe

Type : text

Keywords : open, data, institutions, internet, base, description, www, via, service, position, is, in, name, source, city, building, by, 1, 25, 100, area, further, work, developing, most, on, and, when, development, partnership, focus, for, to, education, aid, world, as, million, it, not, 2012, specific, international, areas, support, 20, partner, targets, paris, through, this, sector, global, countries, are, please, our, or, value, social, digital, house, information, 10, 3, 15, that, economy, based, out, america, equity, a, 4, 6, general, ii, m, 27, france, complement, 30, s, 0, funding, their, local, be, first, internal, which, under, market, services, e, six, all, organisation, long, assets, its, into, access, can, groups, takes, region, opportunity, human, different, opportunities, using, either, distribution, more, an, science, 19, com, from, partners, us, led, available, other, lead, non, possible, years, at, integrated, including, capacity, where, set, earth, network, i, finance, ten, per, transactions, product, number, innovation, energy, sustainable, launched, worldwide, three, assessing, key, 1997, lower, real, class, between, any, mission, 1978, role, creation, 22, start, up, next, only, those, care, five, health, who, primary, use, high, fourth, closely, switzerland, comprises, 2008, price, managed, funds, basis, revenue, established, provide, additional, tools, looks, of, best, working, issues, regions, 16, direction, experience, europe, 2001, prevention, important, nature, eu, private, resources, presence, 2005, simple, 500, netherlands, credit, performance, products, stage, pre, 1999, relevant, depth, cap, new, 40, twitter, facebook, main, pri, 59, eur, t, 90, 2002, denmark, have, but, millions, collective, cycle, active, over, aggregate, needed, across, last, uk, also, goods, articles, single, india, been, seed, generally, consumer, financial, co, large, growth, acquisition, completed, home, such, solely, we, make, looking, understands, knowledge, concept, combines, both, published, these, within, has, two, enterprise, them, one, however, since, analytics, sub, some, small, states, early, east, asia, euro, european, late, developed, north, south, making, austria, belgium, china, generation, germany, rice, israel, italy, around, luxembourg, 160, northern, norway, works, sao, singapore, dutch, spain, dispose, sweden, realise, turkey, united, 2019, unique, employees, arm, visit, 130, pan, 191, 81, usa, need, 1980, april, western, 250, success, quality, offices, 2003, 1992, 600, together, mobile, see, than, critical, medium, being, advantage, family, impact, vision, concessions, understanding, life, the, journal, objective, alternative, special, well, capabilities, potential, provides, help, sciences, 1998, managing, boston, space, term, expertise, goal, senior, gene, capital, achieve, scale, 1989, formats, nations, broad, limited, record, york, markets, board, stand, acquisitions, become, lines, valuation, tech, often, 185, currently, reached, challenges, joint, prior, fund, series, london, hard, transformation, priority, core, providers, strategies, develop, sep, built, future, trade, operates, institutional, exclusive, vertical, march, target, young, payment, chemistry, fraud, look, patients, independent, online, commitment, bb, vc, seek, providing, committed, foundation, technology, investor, investment, debt, ev, industrial, amsterdam, management, without, spanish, principles, owned, financing, 800, ai, made, scientific, targeted, advice, 212, alone, ownership, extensive, composed, mid, initial, portfolio, highly, expanding, infrastructure, performing, supports, cloud, latour, come, carry, bellevue, saas, merck, due, sales, retail, sectors, insurance, lending, investors, deposit, personal, business, individuals, investments, operating, corporations, suppliers, defining, software, intellectual, proprietary, industry, sold, you, forms, ict, pension, firm, significant, professionals, medical, excellence, covering, exit, approximately, ranging, 300, innovations, atlantic, horizon, drive, big, spirit, german, entrepreneurs, oslo, stockholm, considerable, visions, industries, companies, enabled, manager, advanced, recently, brussels, seeking, separate, road, addition, complexity, competitive, globally, down, primarily, deep, producing, friend, expand, buy, provider, customers, smes, revenues, billion, consists, largest, corporate, differentiated, particular, specifically, expertises, diagnostics, company, phases, rna, with, 784, drugs, ultimate, approach, leader, cell, solutions, quest, asset, strong, attractive, lp, firms, healthcare, located, returns, variety, raised, transaction, seen, minority, leading, entrepreneurial, flexibility, driven, makes, add, follow, stronger, venture, networks, specialized, criteria, vehicles, seps, managers, estate, aim, businesses, shareholder, directors, entrepreneur, experienced, promising, clear, executives, emphasis, invest, partnerships, upon, answer, build, strategy, benelux, pai, munich, rif, biotech, diligence, leaders, great, analytical, materials, team, therapeutics, improvement, adding, sourcing, silicon, platforms, england, accelerator, valley, proven, emea, esg, 3i, benefit, orchestra, fast, cgs, ups, emergence, technological, half, criteo, faces, capricorn, advisory, creating, shift, nordic, platform, fundraising, create, tmt, ideas, towards, strategic, ensuring, beyond, identify, particularly, dedicated, offers, investing, medicine, launch, facilitated, focuses, shanghai, horizontal, talent, paulo, omnes, view, want, turn, hands, mln, mena, io, manchester, affiliated, academic, thesis, arkiv, courage, understand, relationships, demonstrate, reach, ensures, transforming, unmet, supporting, majority, track, backing, consistently, deliver, rim, treatments, ventures, ik, allowing, encourage, thematic, operational, enabling, focused, talented, successful, expect, throughout, portfolios, quoted, specialist, lancet, generalist, focusing, therapy, drug, underway, journey, recognised, supportive, advisor, teams, grow, speaking, saw, founder, abbreviation, invested, eu10, acts, significantly, originates, whilst, numerous, backed, ambitious, bringing, eur10, scaled, charities, rapidly, structuring, growing, attracted, thirteen, define, prestigious, straight, leverage, innovative, founded, hadean, headquartered, manages, amongst, sized, alongside, inception, responsible, winning, potentially, helping, corporates, capitalist, founders, eu1, eu4, collectively, rounds, predicated, scandinavia, reputation, signatory, complementary, scorpio, adhering, profitable, dow, ourselves, viable, sustaining, computing, annum, isn, biotechnology, therapies, offerings, playing, extraordinary, targeting, privileged, comfortable, mangrove, scientists, doors, clayton, proof, eu200, darmstadt, ecosystem, promptly, realities, audacious, collaborates, bangalore, biological, bedrock, europes, pools, pioneering, finch, rebels, fulfill, operationally, sponsors, disruptive, maximise, executes, hubs, leisure, journals, childrens, nyse, eur3, leverages, eu3, cerberus, specialising, ambitions, advises, sectorial, randstad, eu65, kgaa, euronext, curative, eu80, eu800, knowledgeable, buyouts, buyout, oakley, cybersecurity, mews, ipo, ipos, invests, pfaffikon, nordics, latam, sicav, eu500, verticals, b2b, changers, dach, fintech, industrials, hpe, pureos, asiapac, adara, unrivalled, thoughtful, chequers, sigfox, transformational, inflexion, bgv, underperforming, medtech, elaia, omnescapital, ikinvest, ysios, biogeneration, vidici, earlybird, microbiome, gilde, cleantech, midcap, mendix, 4bio, cdandr, eu300m, eu50m, teads, agriconomie, eu350m, mirakl, multilocal, bioventures, tinyclues, mercks, 4biocapital, eu80m, pureosbio, industrialtech, 4bios, bbbiotechventures, adomik, dubilier, internationnally, easyrecrue, zivver, henq, seoshop, cipiopartners, opcapita, anacap, 126m, palamon, underperfoming, innvierte, heartcore, earlybirdvc, cipio, adaras, kreos, anacaps, seroba, investee, biofund

Dataset

Data row number Company Description
1 Oakley Capital is a mid-market private equity investor with €3 billion under management, investing primarily in Western Europe. Our sectors are Digital Consumer, TMT and Education. We often buy from founders who are attracted by our entrepreneurial approach and we are comfortable with complexity.
2 Latour Capital makes majority and minority investments in growth companies. We make investments in buyout and growth capital transactions, with an internal co-investment capacity allowing to carry out significant investments as majority or minority shareholder, on companies based in France and Europe, with an enterprise value between €50m and €300m. We have a generalist approach with, however, a focus on business services. We focus on primary transactions.
3 Established in 2008, HPE Growth ('HPE') is a European private equity firm, focusing on late-stage growth investments in small and mid-cap technology companies within the Netherlands, Germany and Belgium. It's main focus is on stand-alone investment opportunities in which it can invest EUR 10-30 mln for a significant minority position. HPE has an active approach both in sourcing and creating value in portfolio companies.
4 IK Investment Partners (“IK”) is a Pan-European private equity firm focused on investments in the Nordics, DACH region, France, and Benelux. Since 1989, IK Funds have raised more than €10 billion of capital and invested in over 130 European companies. IK Funds invest together with management teams in mid-sized companies that have strong improvement potential, operating in the business services, care, industrial goods and consumer goods sectors. For more information visit www.ikinvest.com
5 Founded in 2005, Adara Ventures is a European Venture Capital firm investing in early stage deep tech companies in the European Atlantic rim, with a particular focus on Cybersecurity, Horizontal and Vertical Data/AI solutions, Cloud computing, and Enterprise/Industrial software. Specialized in helping European companies expand globally, half of Adara’s portfolio companies have either scaled from their home-base to Silicon Valley or have reached an exit in that market.
6 Founded in 2002, Elaia Partners is an independent venture capital firm, focused on the digital economy and deep tech. Elaia Partners has more than €350m under management and invests in high-potential disruptive start-ups, from the first financing rounds to the emergence of global leaders. Elaia Partners has been early investor in companies such as Sigfox, Criteo, Shift Technology, Teads, Mirakl, Agriconomie, tinyclues, Talent.io, Orchestra Network, adomik, EasyRECrue,...
7 Earlybird is a venture capital investor focused on European technology companies. Founded in 1997, Earlybird invests in all growth and development phases of a company. Amongst the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources, but also strategic and operational support as well as access to an international network and capital markets. With over EUR 800 million under management, six IPOs and 22 trade sales, Earlybird is one of the most successful venture capital firms in Europe. Further information is available at www.earlybird.com, follow us on Twitter: www.twitter.com/earlybirdvc or become a friend on Facebook: www.facebook.com/EarlybirdVC
8 Earlybird is a venture capital investor focused on European technology companies. Founded in 1997, Earlybird invests in all growth and development phases of a company. Amongst the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources, but also strategic and operational support as well as access to an international network and capital markets. With over EUR 800 million under management, six IPOs and 22 trade sales, Earlybird is one of the most successful venture capital firms in Europe. Further information is available at www.earlybird.com, follow us on Twitter: www.twitter.com/earlybirdvc or become a friend on Facebook: www.facebook.com/EarlybirdVC
9 General Atlantic has been a global growth investor since 1980. We invest in five sectors (Internet & Technology, Business Services, Financial Services, Healthcare, Retail & Consumer) across five regions (US, EMEA, LatAm, China, India, AsiaPac), targeting rapidly growing companies with differentiated technology and services offerings. We are an active strategic partner to entrepreneurs, family-owned businesses & corporations, investing in ~15 companies per annum.
10 None
11 IK Investment Partners (“IK”) is a Pan-European private equity firm focused on investments in the Nordics, DACH region, France, and Benelux. Since 1989, IK Funds have raised more than €10 billion of capital and invested in over 130 European companies. IK Funds invest together with management teams in mid-sized companies that have strong improvement potential, operating in the business services, care, industrial goods and consumer goods sectors. For more information visit www.ikinvest.com
12 AnaCap Financial Partners is a leading specialist private equity firm in the European financial services sector. Based in London, AnaCap has raised more than €4.4 billion under management across Private Equity and Credit vehicles, as well as co-invest.The name AnaCap, an abbreviation of 'Analytical Capital', forms the bedrock upon which our organisation is built. AnaCap takes a highly analytical approach towards the valuation and due diligence of potential investments, which is facilitated by the use of proprietary tools to price assets and which leverages our best-in-class, in-house capabilities.AnaCap’s extensive financial services sector track record and expertise, as well as the structuring of our funds between separate private equity and credit pools ensures that we are an attractive partner for a broad variety of financial institutions looking to dispose of non-core platforms or portfolios of assets, and management teams seeking a partner that understands their business.
13 Oakley Capital is a mid-market private equity investor with €3 billion under management, investing primarily in Western Europe. Our sectors are Digital Consumer, TMT and Education. We often buy from founders who are attracted by our entrepreneurial approach and we are comfortable with complexity.
14 With 300 million Euro under management, Target Partners is one of the leading venture capital investors in Europe.Target Partners invests in young technology companies in Germany, Austria and Switzerland. Through our personal commitment, a global network and our deep experience as entrepreneurs, managers and venture capital investors, we support you in building a great company.The partners of Target Partners have years of collective experience as successful managers, entrepreneurs and venture capital investors in Europe and the USA.We founded or led companies ourselves, developed or sold technology products ourselves. We have seen numerous companies through to IPO and beyond. We understand the challenges an entrepreneur faces and that the road to success often isn't simple and straight.Both in Europe and the USA Target Partners has a large network in industry and venture capital. We open doors for you to customers, partners, experienced managers and financial markets.
15 Founded in 2005, Adara Ventures is a European Venture Capital firm investing in early stage deep tech companies in the European Atlantic rim, with a particular focus on Cybersecurity, Horizontal and Vertical Data/AI solutions, Cloud computing, and Enterprise/Industrial software. Specialized in helping European companies expand globally, half of Adara’s portfolio companies have either scaled from their home-base to Silicon Valley or have reached an exit in that market.
16 Founded in 2005, Adara Ventures is a European Venture Capital firm investing in early stage deep tech companies in the European Atlantic rim, with a particular focus on Cybersecurity, Horizontal and Vertical Data/AI solutions, Cloud computing, and Enterprise/Industrial software. Specialized in helping European companies expand globally, half of Adara’s portfolio companies have either scaled from their home-base to Silicon Valley or have reached an exit in that market.
17 Digital+ Partners is a growth equity investor focused on B2B technology companies. Our aim is to invest in companies with best-in-class technology and help scale them up into global digital leaders. Digital+ is active in Germany and internationnally with a particular focus on companies in the IndustrialTech and FinTech verticals.
18 BioGeneration Ventures (BGV) is a life sciences venture capital firm, with focus on early stage European biotech, medtech, and diagnostics companies. BGV has a strong track record of strong financial returns through investing in innovations in healthcare and providing in depth expertise. BGV manages funds investing in areas where the science, the unmet medical need, and the potential to promptly demonstrate a significant proof of concept come together.
19 Capricorn Partners is an independent European manager of venture capital and equity funds, investing in innovative companies with technology as competitive advantage. The investment team of Capricorn is composed of experienced investment managers with deep technology expertise and a broad industrial experience. Capricorn Partners is investing out of the private venture capital funds Capricorn Digital Growth Fund, Capricorn Sustainable Chemistry Fund, Capricorn ICT Arkiv Fund and Capricorn Health-tech Fund. In addition, Capricorn Partners, in a joint venture with the China based Capricorn Scorpio Investment Management, acts as the exclusive investment advisor of the China – Belgium (Europe) Technology Innovative Industry Fund. Capricorn Partners is also the management company of Quest for Growth, quoted on NYSE Euronext Brussels, and the investment manager of Quest Cleantech Fund and Quest+, sub-funds of Quest Management SICAV.
20 PAI is one of the leading private equity investors in Europe and the recognised leader in France. PAI combines an industrial approach to private equity ownership with sector expertise developed through a large number of investments focusing on five core industries. This strategy has enabled PAI to develop extensive transaction and sectorial expertise in consumer goods, retail and distribution, business services, general industrials and healthcare. PAI's sector knowledge is integrated with its strong local presence to source investment opportunities primarily in France, Italy, Spain, the UK, Germany and Scandinavia.
21 Capricorn Partners is an independent European manager of venture capital and equity funds, investing in innovative companies with technology as competitive advantage. The investment team of Capricorn is composed of experienced investment managers with deep technology expertise and a broad industrial experience. Capricorn Partners is investing out of the private venture capital funds Capricorn Digital Growth Fund, Capricorn Sustainable Chemistry Fund, Capricorn ICT Arkiv Fund and Capricorn Health-tech Fund. In addition, Capricorn Partners, in a joint venture with the China based Capricorn Scorpio Investment Management, acts as the exclusive investment advisor of the China – Belgium (Europe) Technology Innovative Industry Fund. Capricorn Partners is also the management company of Quest for Growth, quoted on NYSE Euronext Brussels, and the investment manager of Quest Cleantech Fund and Quest+, sub-funds of Quest Management SICAV.
22 Omnes is a leading Paris-based European investor in private equity and infrastructure. With €3.6 billion of assets under management, Omnes provides SMEs with the capital needed to finance growth. The firm has dedicated investment teams across three key areas: Venture Capital, Buyout & Growth Capital and Infrastructure. Omnes is owned by its employees. It is committed to ESG issues and has set up the Omnes Foundation in aid of children’s charities. Omnes is also a signatory to the United Nations Principles for Responsible Investment (PRI).Further information: www.omnescapital.com
23 With BB Biotech Ventures, Bellevue currently advises two limited partnerships that have invested in 27 biotech, medtech and healthcare services companies in Switzerland, the EU and the US. Recently, Bellevue has launched the fundraising for BB Pureos Bioventures, a new venture capital fund to invest in innovative drug development companies with a special emphasis on the next generation of biological drugs and drug formats. See www.bbbiotechventures.com, www.pureosbio.com
24 IK Investment Partners (“IK”) is a Pan-European private equity firm focused on investments in the Nordics, DACH region, France, and Benelux. Since 1989, IK Funds have raised more than €10 billion of capital and invested in over 130 European companies. IK Funds invest together with management teams in mid-sized companies that have strong improvement potential, operating in the business services, care, industrial goods and consumer goods sectors. For more information visit www.ikinvest.com
25 Ysios Capital is a leading Spanish independent venture capital firm that provides private equity financing to early- and mid-stage human healthcare and life science companies. We target the biotechnology industry, with an exclusive focus on therapeutics. Founded in 2008, Ysios Capital has € 191,6 million in assets under management through its two funds: Ysios BioFund I (€65 M) and Ysios BioFund II Innvierte (€ 126M). We aim to create value by providing talented entrepreneurs with the resources and tools to achieve success in transforming intellectual capital and scientific knowledge into successful companies.
26 henQ is a Dutch seed/pre-series-A Venture Capitalist, focused on B2B (enterprise) software companies in the Netherlands and Northern Europe in general. Over the last 15 years, henQ has invested in B2B companies as Mendix, SEOshop, Mews and ZIVVER. Currently investing from the fourth fund (€80M).
27 Inflexion is a leading UK mid-market private equity firm, investing in high growth, entrepreneurial businesses with ambitious management teams and working in partnership with them to deliver growth. Inflexion provides complementary investment solutions backing buyouts, as well as minority investments through its partnership capital team. Investing across sectors from offices in London and Manchester. Inflexion also has teams in Bangalore, Sao Paulo, Shanghai & Boston dedicated to portfolio development, enabling investee companies to benefit from privileged access to these fast growth markets. The firm has in-house digital expertise, invests in operational improvement and supports growth via acquisition.
28 OpCapita is a private investment firm specialising in the operational transformation of underperfoming businesses in the retail, consumer and leisure sectors in Europe. OpCapita invests in businesses of scale which are operationally underperforming and where it can identify specific areas of operational improvement to drive long-term, sustainable value creation.
29 PAI is one of the leading private equity investors in Europe and the recognised leader in France. PAI combines an industrial approach to private equity ownership with sector expertise developed through a large number of investments focusing on five core industries. This strategy has enabled PAI to develop extensive transaction and sectorial expertise in consumer goods, retail and distribution, business services, general industrials and healthcare. PAI's sector knowledge is integrated with its strong local presence to source investment opportunities primarily in France, Italy, Spain, the UK, Germany and Scandinavia.
30 PAI is one of the leading private equity investors in Europe and the recognised leader in France. PAI combines an industrial approach to private equity ownership with sector expertise developed through a large number of investments focusing on five core industries. This strategy has enabled PAI to develop extensive transaction and sectorial expertise in consumer goods, retail and distribution, business services, general industrials and healthcare. PAI's sector knowledge is integrated with its strong local presence to source investment opportunities primarily in France, Italy, Spain, the UK, Germany and Scandinavia.
31 Palamon Capital Partners, LP is an independent private equity partnership founded in 1999, which is focused on providing equity for European growth services companies. Palamon originates, executes and manages investments on a pan-European basis, with a particular focus on the UK, Germany, Benelux, Italy, Spain, Norway, Denmark and Sweden. The Firm targets investments in companies where it can be the lead private equity provider and where it can provide strategic direction and partner with management to help build equity value. The Firm manages funds with €1.3 billion of equity capital for investment.
32 Founded in 2003, Cipio Partners is a leading investment management and advisory firm for European Growth Capital & Minority Buyouts for Technology Companies. Cipio Partners targets European growth stage technology businesses with EUR10-100 million in revenue and makes initial investments ranging from EUR3-10 million. Cipio Partners operates from offices in Luxembourg and Munich. Further information is available at www.cipiopartners.com
33 Hadean Ventures is a Life Science Fund manager that invests in life science companies across Europe with a particular focus on the Nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in Oslo and Stockholm and collaborates with world-class academic institutions and start-up hubs across the region.
34 Hadean Ventures is a Life Science Fund manager that invests in life science companies across Europe with a particular focus on the Nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in Oslo and Stockholm and collaborates with world-class academic institutions and start-up hubs across the region.
35 Randstad Innovation Fund (RIF) is the strategic corporate venture fund of Randstad and is building a portfolio of early stage technology companies. RIF invests in the area of social sourcing, online platforms, mobile solutions and big data analytics. Its goal is to create an ecosystem where Randstad's expertise and reach complement entrepreneurial spirit and technological excellence.
36 Dow Venture Capital invests in promising start-up companies in North America, Europe and Asia. We support our portfolio with capital, technology and a global network of potential development partners. We have invested over US$ 500 millions in sustaining our companies throughout their early critical years.
37 4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector. 4BIO’s objective is to invest in, support, and grow early-stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially curative therapies for all patients. Specifically, it looks for viable, high-quality opportunities in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome.The 4BIO team comprises leading advanced therapy scientists and experienced life science investors who have collectively published over 250 scientific articles in prestigious academic journals including Nature, The Lancet, Cell, and the New England Journal of Medicine. 4BIO has both an unrivalled network within the advanced therapy sector and a unique understanding of the criteria that define a successful investment opportunity in this space.For more information, please visit www.4biocapital.com
38 Digital+ Partners is a growth equity investor focused on B2B technology companies. Our aim is to invest in companies with best-in-class technology and help scale them up into global digital leaders. Digital+ is active in Germany and internationnally with a particular focus on companies in the IndustrialTech and FinTech verticals.
39 Founded in 1978, Clayton, Dubilier & Rice is a private investment firm with an investment strategy predicated on producing financial returns through building stronger, more profitable businesses. Since inception, CD&R has managed the investment of more than $19 billion in 59 businesses with an aggregate transaction value of more than $90 billion.
40 CGS is an independent, experienced industry partner based in Pfäffikon, Switzerland. CGS is specialized in building medium-sized companies into international groups and expanding their business. Since 1999, CGS funds have been investing in platform companies in Europe’s German-speaking countries and making add-on acquisitions worldwide.
41 Gilde Healthcare is a specialized European healthcare investor managing two business lines: a venture & growth capital fund and a lower mid-market buy-out fund. Gilde Healthcare's venture & growth capital fund invests in medtech, diagnostics, digital health and therapeutics. The portfolio companies are based in Europe and North America. Gilde Healthcare's lower mid-market buy-out fund invests in profitable European healthcare services companies with a focus on the Netherlands, Belgium and Germany. The portfolio consists of healthcare providers, suppliers of medical products and other service providers in the healthcare market. Since 2001 Gilde Healthcare has raised €800 million ($1 billion) for its specialized funds.
42 Finch Capital is a venture capital firm investing in early stage financial technology businesses in Europe and South East Asia. We are thematic investors with our investment thesis focusing on the transformation underway in the financial services sector. Operating out of offices in Amsterdam, London and Singapore, it makes significant minority investments. Finch Capital is an active investor supporting its portfolio companies by being on the board and playing an important role in defining strategy and helping with business development including its funding. Finch Capital has made 25 investments since its inception covering deposit and lending, fraud prevention, investments, payment and insurance businesses.
43 Oakley Capital is a mid-market private equity investor with €3 billion under management, investing primarily in Western Europe. Our sectors are Digital Consumer, TMT and Education. We often buy from founders who are attracted by our entrepreneurial approach and we are comfortable with complexity.
44 3i is a leading international investment manager focused on mid-market Private Equity and Infrastructure. Our core markets are northern Europe and North America.
45 3i is a leading international investment manager focused on mid-market Private Equity and Infrastructure. Our core markets are northern Europe and North America.
46 3i is a leading international investment manager focused on mid-market Private Equity and Infrastructure. Our core markets are northern Europe and North America.
47 3i is a leading international investment manager focused on mid-market Private Equity and Infrastructure. Our core markets are northern Europe and North America.
48 Seroba is a European life sciences venture capital firm focused on investing in winning innovations in biotech and medtech. The team has deep investment and industry experience enabling Seroba to help entrepreneurs realise their ambitions whilst creating value for investors. Seroba partners with entrepreneurs to create and build businesses around extraordinary science.
49 Heartcore is our answer to the new generation of founders who seek a more human approach to venture capital and want to work with a team that not only supports them in growing their businesses, but also as individuals. We provide financing for the audacious, the rebels, the world-changers - to those who have the courage to see and build our joint future.
50 Heartcore is our answer to the new generation of founders who seek a more human approach to venture capital and want to work with a team that not only supports them in growing their businesses, but also as individuals. We provide financing for the audacious, the rebels, the world-changers - to those who have the courage to see and build our joint future.
51 Seroba is a European life sciences venture capital firm focused on investing in winning innovations in biotech and medtech. The team has deep investment and industry experience enabling Seroba to help entrepreneurs realise their ambitions whilst creating value for investors. Seroba partners with entrepreneurs to create and build businesses around extraordinary science.
52 IK Investment Partners (“IK”) is a Pan-European private equity firm focused on investments in the Nordics, DACH region, France, and Benelux. Since 1989, IK Funds have raised more than €10 billion of capital and invested in over 130 European companies. IK Funds invest together with management teams in mid-sized companies that have strong improvement potential, operating in the business services, care, industrial goods and consumer goods sectors. For more information visit www.ikinvest.com
53 IK Investment Partners (“IK”) is a Pan-European private equity firm focused on investments in the Nordics, DACH region, France, and Benelux. Since 1989, IK Funds have raised more than €10 billion of capital and invested in over 130 European companies. IK Funds invest together with management teams in mid-sized companies that have strong improvement potential, operating in the business services, care, industrial goods and consumer goods sectors. For more information visit www.ikinvest.com
54 Cerberus Capital Management is a global alternative investment firm founded in 1992. The Firm is headquartered in New York City, has thirteen affiliated and advisory offices located in the United States, South America, Europe and Asia, and has 784 employees worldwide as of April 1,2019. Cerberus generally has a long-term investment horizon and focuses on value creation globally in credit, private equity and real estate strategies. Cerberus has approximately $40 billion of assets under management as of March 1,2019. Approximately 185 dedicated investment professionals are integrated across all three of the Firm’s investment strategies, bringing considerable expertise in assessing and managing Cerberus’ investments. Cerberus has 81 Senior Executives or Managing Directors that have been with the Firm for ten years or more.
55 Cerberus Capital Management is a global alternative investment firm founded in 1992. The Firm is headquartered in New York City, has thirteen affiliated and advisory offices located in the United States, South America, Europe and Asia, and has 784 employees worldwide as of April 1,2019. Cerberus generally has a long-term investment horizon and focuses on value creation globally in credit, private equity and real estate strategies. Cerberus has approximately $40 billion of assets under management as of March 1,2019. Approximately 185 dedicated investment professionals are integrated across all three of the Firm’s investment strategies, bringing considerable expertise in assessing and managing Cerberus’ investments. Cerberus has 81 Senior Executives or Managing Directors that have been with the Firm for ten years or more.
56 Finch Capital is a venture capital firm investing in early stage financial technology businesses in Europe and South East Asia. We are thematic investors with our investment thesis focusing on the transformation underway in the financial services sector. Operating out of offices in Amsterdam, London and Singapore, it makes significant minority investments. Finch Capital is an active investor supporting its portfolio companies by being on the board and playing an important role in defining strategy and helping with business development including its funding. Finch Capital has made 25 investments since its inception covering deposit and lending, fraud prevention, investments, payment and insurance businesses.
57 SEP is a long-established, and consistently high performing, venture capital and growth equity firm with one of the most experienced teams in Europe. SEP has been building businesses for over 20 years, enabling founder led teams to achieve their ambitions. Providing investment, alongside expertise and access to an international network, SEP’s knowledgeable and down to earth team work hard to help management maximise company growth and value. Technology focused, with particular expertise in SaaS, consumer internet, energy technology and tech enabled service businesses, SEP has been a supportive investor to more than 160 companies, including some of Europe’s most successful. SEP is a responsible investor adhering to ESG principles and has raised its funds from global financial institutions, asset management companies, pension funds, family offices and corporates.
58 SEP is a long-established, and consistently high performing, venture capital and growth equity firm with one of the most experienced teams in Europe. SEP has been building businesses for over 20 years, enabling founder led teams to achieve their ambitions. Providing investment, alongside expertise and access to an international network, SEP’s knowledgeable and down to earth team work hard to help management maximise company growth and value. Technology focused, with particular expertise in SaaS, consumer internet, energy technology and tech enabled service businesses, SEP has been a supportive investor to more than 160 companies, including some of Europe’s most successful. SEP is a responsible investor adhering to ESG principles and has raised its funds from global financial institutions, asset management companies, pension funds, family offices and corporates.
59 Founded in 1978, Clayton, Dubilier & Rice is a private investment firm with an investment strategy predicated on producing financial returns through building stronger, more profitable businesses. Since inception, CD&R has managed the investment of more than $19 billion in 59 businesses with an aggregate transaction value of more than $90 billion.
60 M Ventures is the strategic, corporate venture arm of Merck KGaA, Darmstadt, Germany. We invest globally in transformational ideas driven by great entrepreneurs that have the potential to significantly impact Merck's core business areas, i.e. Healthcare, Life Sciences, Performance Materials and New Businesses. We have a significant focus on early stage investing and company creation to leverage Merck’s science and technology base. We are hands-on investors and provide significant support to early stage companies through access to our broad networks and internal expertises.
61 BioGeneration Ventures (BGV) is a life sciences venture capital firm, with focus on early stage European biotech, medtech, and diagnostics companies. BGV has a strong track record of strong financial returns through investing in innovations in healthcare and providing in depth expertise. BGV manages funds investing in areas where the science, the unmet medical need, and the potential to promptly demonstrate a significant proof of concept come together.
62 Founded in 2005, Adara Ventures is a European Venture Capital firm investing in early stage deep tech companies in the European Atlantic rim, with a particular focus on Cybersecurity, Horizontal and Vertical Data/AI solutions, Cloud computing, and Enterprise/Industrial software. Specialized in helping European companies expand globally, half of Adara’s portfolio companies have either scaled from their home-base to Silicon Valley or have reached an exit in that market.
63 IK Investment Partners (“IK”) is a Pan-European private equity firm focused on investments in the Nordics, DACH region, France, and Benelux. Since 1989, IK Funds have raised more than €10 billion of capital and invested in over 130 European companies. IK Funds invest together with management teams in mid-sized companies that have strong improvement potential, operating in the business services, care, industrial goods and consumer goods sectors. For more information visit www.ikinvest.com
64 Established in 2008, HPE Growth ('HPE') is a European private equity firm, focusing on late-stage growth investments in small and mid-cap technology companies within the Netherlands, Germany and Belgium. It's main focus is on stand-alone investment opportunities in which it can invest EUR 10-30 mln for a significant minority position. HPE has an active approach both in sourcing and creating value in portfolio companies.
65 212 is the leading VC fund in Turkey with focus on Europe, Turkey and MENA since 2012
66 Vidici Ventures (Vidici Fund I, Vidici Fund II & “Vidici”) is a leading Nordic FinTech investor, founded in 2012 by entrepreneurs who saw the opportunity to develop a FinTech-focused venture capital fund in the Nordic Region. Vidici works together with entrepreneurs and management teams to create winning partnerships that drive the long-term development of high potential FinTech companies.
67 IK Investment Partners (“IK”) is a Pan-European private equity firm focused on investments in the Nordics, DACH region, France, and Benelux. Since 1989, IK Funds have raised more than €10 billion of capital and invested in over 130 European companies. IK Funds invest together with management teams in mid-sized companies that have strong improvement potential, operating in the business services, care, industrial goods and consumer goods sectors. For more information visit www.ikinvest.com
68 Earlybird is a venture capital investor focused on European technology companies. Founded in 1997, Earlybird invests in all growth and development phases of a company. Amongst the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources, but also strategic and operational support as well as access to an international network and capital markets. With over EUR 800 million under management, six IPOs and 22 trade sales, Earlybird is one of the most successful venture capital firms in Europe. Further information is available at www.earlybird.com, follow us on Twitter: www.twitter.com/earlybirdvc or become a friend on Facebook: www.facebook.com/EarlybirdVC
69 Earlybird is a venture capital investor focused on European technology companies. Founded in 1997, Earlybird invests in all growth and development phases of a company. Amongst the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources, but also strategic and operational support as well as access to an international network and capital markets. With over EUR 800 million under management, six IPOs and 22 trade sales, Earlybird is one of the most successful venture capital firms in Europe. Further information is available at www.earlybird.com, follow us on Twitter: www.twitter.com/earlybirdvc or become a friend on Facebook: www.facebook.com/EarlybirdVC
70 Earlybird is a venture capital investor focused on European technology companies. Founded in 1997, Earlybird invests in all growth and development phases of a company. Amongst the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources, but also strategic and operational support as well as access to an international network and capital markets. With over EUR 800 million under management, six IPOs and 22 trade sales, Earlybird is one of the most successful venture capital firms in Europe. Further information is available at www.earlybird.com, follow us on Twitter: www.twitter.com/earlybirdvc or become a friend on Facebook: www.facebook.com/EarlybirdVC
71 General Atlantic has been a global growth investor since 1980. We invest in five sectors (Internet & Technology, Business Services, Financial Services, Healthcare, Retail & Consumer) across five regions (US, EMEA, LatAm, China, India, AsiaPac), targeting rapidly growing companies with differentiated technology and services offerings. We are an active strategic partner to entrepreneurs, family-owned businesses & corporations, investing in ~15 companies per annum.
72 M Ventures is the strategic, corporate venture arm of Merck KGaA, Darmstadt, Germany. We invest globally in transformational ideas driven by great entrepreneurs that have the potential to significantly impact Merck's core business areas, i.e. Healthcare, Life Sciences, Performance Materials and New Businesses. We have a significant focus on early stage investing and company creation to leverage Merck’s science and technology base. We are hands-on investors and provide significant support to early stage companies through access to our broad networks and internal expertises.
73 General Atlantic has been a global growth investor since 1980. We invest in five sectors (Internet & Technology, Business Services, Financial Services, Healthcare, Retail & Consumer) across five regions (US, EMEA, LatAm, China, India, AsiaPac), targeting rapidly growing companies with differentiated technology and services offerings. We are an active strategic partner to entrepreneurs, family-owned businesses & corporations, investing in ~15 companies per annum.
74 Chequers Capital invests in Midcap companies with an EV between €80 and €500 million using leverage when possible. Chequers Capital operates as a single team from multilocal offices with clear priority for France, Germany, Italy, Benelux, Switzerland and Spain.
75 Earlybird is a venture capital investor focused on European technology companies. Founded in 1997, Earlybird invests in all growth and development phases of a company. Amongst the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources, but also strategic and operational support as well as access to an international network and capital markets. With over EUR 800 million under management, six IPOs and 22 trade sales, Earlybird is one of the most successful venture capital firms in Europe. Further information is available at www.earlybird.com, follow us on Twitter: www.twitter.com/earlybirdvc or become a friend on Facebook: www.facebook.com/EarlybirdVC
76 IK Investment Partners (“IK”) is a Pan-European private equity firm focused on investments in the Nordics, DACH region, France, and Benelux. Since 1989, IK Funds have raised more than €10 billion of capital and invested in over 130 European companies. IK Funds invest together with management teams in mid-sized companies that have strong improvement potential, operating in the business services, care, industrial goods and consumer goods sectors. For more information visit www.ikinvest.com
77 Founded in 1998, Kreos Capital is Europe and Israel's largest and leading provider of finance to high-growth companies with revenues up to +€200 million. As the pioneering growth debt provider across the UK, Europe, and Israel, Kreos has completed more than 600 transactions and committed +€3.0 billion to companies across 16 different countries over the last +20 years. Kreos has a proven track record of, and reputation for, adding value to portfolio companies - helping them to grow with additional capital and flexibility throughout their business cycle, and working closely with both the portfolio company management team and their equity sponsors.
78 Mangrove Capital Partner’s mission is to help turn visions into realities by providing financing, thoughtful advice, relevant experience & deep industry relationships to our portfolio companies. We look to invest in companies operating internet or software businesses as early as possible. We are particularly comfortable investing prior to product launch. We view our role as an accelerator of growth and a partner for the journey to success. We expect to be alongside the company at all phases of this journey and encourage entrepreneurs to fulfill their vision, without any concessions.
79 Founded in 1998, Kreos Capital is Europe and Israel's largest and leading provider of finance to high-growth companies with revenues up to +€200 million. As the pioneering growth debt provider across the UK, Europe, and Israel, Kreos has completed more than 600 transactions and committed +€3.0 billion to companies across 16 different countries over the last +20 years. Kreos has a proven track record of, and reputation for, adding value to portfolio companies - helping them to grow with additional capital and flexibility throughout their business cycle, and working closely with both the portfolio company management team and their equity sponsors.
80 With BB Biotech Ventures, Bellevue currently advises two limited partnerships that have invested in 27 biotech, medtech and healthcare services companies in Switzerland, the EU and the US. Recently, Bellevue has launched the fundraising for BB Pureos Bioventures, a new venture capital fund to invest in innovative drug development companies with a special emphasis on the next generation of biological drugs and drug formats. See www.bbbiotechventures.com, www.pureosbio.com
81 Founded in 2002, Elaia Partners is an independent venture capital firm, focused on the digital economy and deep tech. Elaia Partners has more than €350m under management and invests in high-potential disruptive start-ups, from the first financing rounds to the emergence of global leaders. Elaia Partners has been early investor in companies such as Sigfox, Criteo, Shift Technology, Teads, Mirakl, Agriconomie, tinyclues, Talent.io, Orchestra Network, adomik, EasyRECrue,...
82 Earlybird is a venture capital investor focused on European technology companies. Founded in 1997, Earlybird invests in all growth and development phases of a company. Amongst the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources, but also strategic and operational support as well as access to an international network and capital markets. With over EUR 800 million under management, six IPOs and 22 trade sales, Earlybird is one of the most successful venture capital firms in Europe. Further information is available at www.earlybird.com, follow us on Twitter: www.twitter.com/earlybirdvc or become a friend on Facebook: www.facebook.com/EarlybirdVC
83 Earlybird is a venture capital investor focused on European technology companies. Founded in 1997, Earlybird invests in all growth and development phases of a company. Amongst the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources, but also strategic and operational support as well as access to an international network and capital markets. With over EUR 800 million under management, six IPOs and 22 trade sales, Earlybird is one of the most successful venture capital firms in Europe. Further information is available at www.earlybird.com, follow us on Twitter: www.twitter.com/earlybirdvc or become a friend on Facebook: www.facebook.com/EarlybirdVC
84 General Atlantic has been a global growth investor since 1980. We invest in five sectors (Internet & Technology, Business Services, Financial Services, Healthcare, Retail & Consumer) across five regions (US, EMEA, LatAm, China, India, AsiaPac), targeting rapidly growing companies with differentiated technology and services offerings. We are an active strategic partner to entrepreneurs, family-owned businesses & corporations, investing in ~15 companies per annum.